Nasdaq Tumbles 4.5%; Cardinal Health Shares Gain After Upbeat Q1 Earnings
U.S. stocks tumbled: Nasdaq -4.5%, S&P 500 -3.3%, Dow -2.5%. Cardinal Health rose on strong results; AppLovin surged 32%, while Veracyte fell 55%.
Stocks · News reference
Cantor Fitzgerald Maintains Overweight on PureCycle Technologies, Lowers Price Target to $12
Cantor Fitzgerald analyst Andres Sheppard maintains PureCycle Technologies (NASDAQ:PCT) with a Overweight and lowers the price target from $14 to $12.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Dow Surges 250 Points; US Weekly Jobless Claims Fall
U.S. stocks mixed: Dow +0.47%, Nasdaq -1.35%, S&P 500 -0.55%. Jobless claims fell to 189,000; oil and gold rose.
PureCycle Technologies Reports Third Quarter 2026 Financial Results
PureCycle Technologies announced its financial results for the third quarter ended September 30, 2026, reporting revenue of $2.3 million and an operating loss of $37.5 million.
PureCycle Technologies Q3 Sales $2.349M Miss $8.278M Estimate
PureCycle to Report Third Quarter 2026 Financial Results on November 4, 2026
PureCycle Technologies, Inc. announced it will release its financial results for the third quarter ended September 30, 2026, after market close on November 4, 2026.
PureCycle Technologies Q2 2026 Earnings Call Transcript
PureCycle Technologies (NASDAQ:PCT) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access